Health X Platform Ltd (HEALTHX) is currently trading at 291.30 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

SastaSundar Ventures Limited (proposed Health X Platform Limited) operates an integrated digital healthcare platform combining pharmaceutical distribution (Retailer Shakti), a B2C pharmacy and wellness app (SastaSundar), diagnostics enablement, and franchise-led last-mile delivery via HealthBuddy. The company holds controlling interest in SastaSundar HealthBuddy Limited and aggregates digital enablement, automated fulfilment centres and retailer SaaS to serve consumers and 62,000+ pharmacies nationwide. In Q3 FY26 SastaSundar reported consolidated healthcare operations revenue of ₹341.3 crore (total revenue ₹359.4 crore), up 22% year-on-year, with gross profit rising 55% and a gross margin of 7.6%; EBITDA loss narrowed to ₹14.8 crore and nine‑month PAT turned positive at ₹11.5 crore, driven materially by higher other income and operating efficiency improvements in procurement and fulfilment automation. The company is aggressively investing in AI and platform monetization—announcing AI integration across counselling, operations and personalized recommendations, a Retail Air SaaS for retailers, and an AI studio budget—while launching the JITO private generic brand to capture value-accretive margin expansion; these initiatives are designed to shift revenue mix, increase gross margins and monetize proprietary data and digital properties. Sastasundar emphasizes capital efficiency: management reports total capital raised of ₹352 crore and discloses a combined treasury of roughly ₹500 crore across group entities (about ₹403 crore in SastaSundar HealthBuddy Limited), consolidated borrowings near zero, and a compact working-capital profile; this liquidity is positioned to fund ₹100+ crore planned platform investments while preserving optionality for buybacks or corporate restructuring.

Over the past 52 weeks, Health X Platform Ltd has traded between a low of ₹252.50 and a high of ₹375.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Health X Platform Ltd has a market capitalization of approximately 933.16. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Health X Platform Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -35.82 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 933.16 Cr, Health X Platform Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Health X Platform Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Health X Platform Ltd is -35.82. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.